Portfolio Diversification
Range
Most Diversified
20 instruments
July 7, 2023
Least Diversified
0 instruments
October 20, 2025
Average
18 instruments
Most Consistent Holdings
Top 5
BDX99.72%
DXCM99.72%
MRK99.64%
ROG.ZU99.64%
AZN.L99.64%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Eli Lilly (LLY) | 11.74% | 9.67% | 99.15% | - |
| Merck (MRK) | 9.08% | 6.49% | 99.64% | - |
 Novo-Nordisk (NVO) | 8.97% | 2.5% | 99.64% | - |
| AstraZeneca (AZN.L) | 6.42% | 5.67% | 99.64% | - |
 Abbott (ABT) | 6.23% | 4.52% | 99.5% | - |
| DexCom (DXCM) | 5.4% | 5.28% | 99.72% | - |
 Medtronic (MDT.US) | 4.88% | 5.35% | 99.5% | - |
 Insulet (PODD) | 4.36% | 5.77% | 99.64% | - |
 Sanofi (SAN.PA) | 3.89% | 3.13% | 99.5% | - |
| Roche (ROG.ZU) | 3.87% | 4.29% | 99.64% | - |
 Johnson & Johnson (JNJ) | 3.81% | 6.68% | 70.23% | - |
| BD (BDX) | 3.64% | 3.64% | 99.72% | - |
 Tandem Diabetes (TNDM) | 2.82% | 2.55% | 99.57% | - |
 Bristol-Myers Squibb (BMY) | 2.81% | 3.92% | 62.25% | - |
 Bayer (BAYN.DE) | 2.54% | 0% | 50.07% | 1/3/2024 |
 Neurocrine Biosciences (NBIX) | 2.5% | 5.84% | 49.15% | - |
 Ascendis Pharma (ASND) | 2.49% | 5.82% | 49.36% | - |
 Halozyme (HALO) | 2.3% | 4.54% | 47.29% | - |
 Alkermes (ALKS) | 2.24% | 4.02% | 48.93% | - |
 MannKind (MNKD) | 2.21% | 3.48% | 65.17% | - |
 Rhythm Pharmaceuticals (RYTM) | 1.34% | 0% | 26.21% | 1/8/2025 |
 Almirall (ALM.MC) | 1.13% | 0% | 50.07% | 1/3/2024 |
 Pfizer (PFE) | 1.1% | 4.66% | 23.01% | - |
 GlaxoSmithKline (GSK) | 1.09% | 0% | 26.21% | 1/8/2025 |
 Sandoz (SDZNY) | 0.65% | 0% | 14.89% | 8/1/2024 |
 GSK (GSK.L) | 0.49% | 0% | 12.61% | 1/3/2024 |
 Lexicon Pharmaceuticals (LXRX) | 0.28% | 0% | 12.68% | 1/3/2024 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Insulet (PODD) | 7.29% | 8% |
| Rhythm Pharmaceuticals (RYTM) | 5.18% | 6.48% |
| Bristol-Myers Squibb (BMY) | 6.58% | 6.19% |
| Johnson & Johnson (JNJ) | 6.93% | 6.11% |
| Eli Lilly (LLY) | 2.07% | 5.63% |
| Alkermes (ALKS) | 5.57% | 5.59% |
| Medtronic (MDT.US) | 6.52% | 5.28% |
| Neurocrine Biosciences (NBIX) | 5.22% | 5.26% |
| Abbott (ABT) | 5.49% | 5.19% |
| Ascendis Pharma (ASND) | 4.66% | 4.97% |
| Halozyme (HALO) | 5.61% | 4.76% |
| BD (BDX) | 5.19% | 4.51% |
| Merck (MRK) | 3.88% | 4.48% |
| DexCom (DXCM) | 6.5% | 4.43% |
| Roche (ROG.ZU) | 5.55% | 4.24% |
| Sanofi (SAN.PA) | 4.54% | 4.23% |
| AstraZeneca (AZN.L) | 4.18% | 4.18% |
| Tandem Diabetes (TNDM) | 2.56% | 3.68% |
| GlaxoSmithKline (GSK) | 4.08% | 3.52% |
| Novo-Nordisk (NVO) | 1.74% | 2.62% |